256 related articles for article (PubMed ID: 24143945)
1. Pulmonary biomarkers in COPD exacerbations: a systematic review.
Koutsokera A; Kostikas K; Nicod LP; Fitting JW
Respir Res; 2013 Oct; 14(1):111. PubMed ID: 24143945
[TBL] [Abstract][Full Text] [Related]
2. Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge.
Koutsokera A; Stolz D; Loukides S; Kostikas K
Chest; 2012 Feb; 141(2):396-405. PubMed ID: 21835899
[TBL] [Abstract][Full Text] [Related]
3. Exhaled biomarkers.
Kharitonov SA; Barnes PJ
Chest; 2006 Nov; 130(5):1541-6. PubMed ID: 17099035
[TBL] [Abstract][Full Text] [Related]
4. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.
MacLeod M; Papi A; Contoli M; Beghé B; Celli BR; Wedzicha JA; Fabbri LM
Respirology; 2021 Jun; 26(6):532-551. PubMed ID: 33893708
[TBL] [Abstract][Full Text] [Related]
5. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
[TBL] [Abstract][Full Text] [Related]
6. Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations.
Shafiek H; Fiorentino F; Merino JL; López C; Oliver A; Segura J; de Paul I; Sibila O; Agustí A; Cosío BG
PLoS One; 2015; 10(9):e0135199. PubMed ID: 26353114
[TBL] [Abstract][Full Text] [Related]
7. The clinical utility of biomarkers in asthma and COPD.
Snell N; Newbold P
Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in COPD.
Tzortzaki EG; Lambiri I; Vlachaki E; Siafakas NM
Curr Med Chem; 2007; 14(9):1037-48. PubMed ID: 17439401
[TBL] [Abstract][Full Text] [Related]
9. Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.
Arostegui I; Esteban C; García-Gutierrez S; Bare M; Fernández-de-Larrea N; Briones E; Quintana JM;
PLoS One; 2014; 9(6):e98580. PubMed ID: 24892936
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects.
Malerba M; Ragnoli B; Corradi M
Monaldi Arch Chest Dis; 2008 Sep; 69(3):128-33. PubMed ID: 19065847
[TBL] [Abstract][Full Text] [Related]
11. Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease.
Bhatt SP; Agusti A; Bafadhel M; Christenson SA; Bon J; Donaldson GC; Sin DD; Wedzicha JA; Martinez FJ
Am J Respir Crit Care Med; 2023 Nov; 208(10):1026-1041. PubMed ID: 37560988
[TBL] [Abstract][Full Text] [Related]
12. Building toolkits for COPD exacerbations: lessons from the past and present.
Sapey E; Bafadhel M; Bolton CE; Wilkinson T; Hurst JR; Quint JK
Thorax; 2019 Sep; 74(9):898-905. PubMed ID: 31273049
[TBL] [Abstract][Full Text] [Related]
13. Coding of COPD Exacerbations and the Implications on Clinical Practice, Audit and Research.
Echevarria C; Steer J; Bourke SC
COPD; 2020 Dec; 17(6):706-710. PubMed ID: 33169617
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?
Hillas G; Loukides S; Kostikas K; Bakakos P
Curr Med Chem; 2009; 16(22):2824-38. PubMed ID: 19689266
[TBL] [Abstract][Full Text] [Related]
15. Multi-level differential network analysis of COPD exacerbations.
Noell G; Cosío BG; Faner R; Monsó E; Peces-Barba G; de Diego A; Esteban C; Gea J; Rodriguez-Roisin R; Garcia-Nuñez M; Pozo-Rodriguez F; Kalko SG; Agustí A
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28954781
[TBL] [Abstract][Full Text] [Related]
16. Exhaled breath condensate biomarkers in COPD.
Borrill ZL; Roy K; Singh D
Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
[TBL] [Abstract][Full Text] [Related]
17. Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?
Cometa M; Ursitti A; Lombardo LP; Rana R; Gardani A; Contoli M; Papi A
Respir Med; 2024 Feb; 222():107509. PubMed ID: 38145723
[TBL] [Abstract][Full Text] [Related]
18. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
Deng DD; Zhou AY; Shuang QC; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
[No Abstract] [Full Text] [Related]
19. Resting Borg score as a predictor of safe discharge of chronic obstructive pulmonary disease from the emergency department observation unit.
Sengupta R; Loftus TM; Doers M; Jandarov RA; Phillips M; Ko J; Panos RJ; Zafar MA
Acad Emerg Med; 2020 Dec; 27(12):1302-1311. PubMed ID: 32678934
[TBL] [Abstract][Full Text] [Related]
20. Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study.
Adir Y; Hakrush O; Shteinberg M; Schneer S; Agusti A
ERJ Open Res; 2018 Jul; 4(3):. PubMed ID: 30083552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
